Machado Patrick
SEC CIK 1311210 · EDGAR
Most active insiders at ALMS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AKKARAJU SRINIVAS | Dir | $29.80M | $1.01M |
| 2 | Tananbaum James B. | Dir, 10% | $10.63M | — |
| 3 | Foresite Labs Fund I, L.P. | 10% | $7.53M | — |
| 4 | Foresite Labs, LLC | 10% | $7.00M | — |
| 5 | Foresite Labs Affiliates 2021, LLC | 10% | $3.63M | — |
| 6 | Foresite Capital Management VI LLC | 10% | $3.09M | — |
| 7 | Pangali Sanam | CLO | — | $176.0K |
| 8 | Schroer John R. | CFO | — | $86.5K |
| 9 | Hardiman Roy C. | Chief Business, Strategy Ofcr | — | $71.0K |
| 10 | Goldstein David M | CSO | — | $68.5K |
| 16 | Machado Patrick | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-02 18:24 | 2026-06-30 | ALMS | ALUMIS INC. | Machado Patrick | Dir | A - Grant | $0.00 | +3,553 | 3,553 | New | $0 |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Arcus Biosciences, Inc. | Machado Patrick | Dir | A - Grant | $0.00 | +5,700 | 44.3K | +15% | $0 |
| D | 2026-06-03 21:04 | 2026-06-01 | XENE | Xenon Pharmaceuticals Inc. | Machado Patrick | Dir | M - OptEx | — | +2,645 | 2,645 | New | — |
| D | 2025-06-12 | 2025-06-10 | RCUS | Arcus Biosciences, Inc. | Machado Patrick | Dir | A - Grant | $0.00 | +13.3K | 38.6K | +53% | $0 |
| DI | 2025-05-23 | 2025-05-21 | ALMS | ALUMIS INC. | Machado Patrick | Dir | A - Grant | — | +7,064 | 7,064 | New | — |
| D | 2024-06-07 | 2024-06-06 | RCUS | Arcus Biosciences, Inc. | Machado Patrick | Dir | A - Grant | $0.00 | +8,400 | 25.3K | +50% | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | Arcus Biosciences, Inc. | Machado Patrick | Dir | A - Grant | $0.00 | +6,800 | 16.9K | +67% | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | Arcus Biosciences, Inc. | Machado Patrick | Dir | A - Grant | $0.00 | +4,100 | 10.1K | +68% | $0 |
Purchase Sale Sale after option exercise All abbreviations